What vaccines will be accepted?
For ships embarking or disembarking at U.S. ports:
- U.S. Food and Drug Administration (FDA) and/or World Health Organization (WHO) authorized single brand vaccination protocol 2 weeks after receipt of the final dose. Including, J&J Janssen, Pfizer-BioNTech, Moderna, AstraZeneca/Oxford (also known as Covishield and Vaxzervria), Sinopharm BIBP and Sinovac. These vaccines are listed as examples. Refer to FDA or WHO websites for full approved current list.
- A mixed vaccination protocol of only Pfizer-BioNTech or Moderna combinations (mRNA vaccines) with a minimum interval of 28 days.
For all other Vessels departing from a non U.S. port:
- Any U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), or World Health Organization (WHO) authorized single brand vaccination protocol 2 weeks after receipt of the final dose.
- A mixed vaccination protocol of only AstraZeneca, Pfizer-BioNTech or Moderna combinations with a minimum interval of 28 days.
Note: Individuals receiving a J&J Janssen COVID-19 vaccine before or after another COVID-19 vaccine are considered fully vaccinated against COVID-19 2 weeks after receipt of the single dose of the J&J Janssen vaccine.
Vaccines received via clinical trials will not be accepted as they do not specify vaccine received.
To be fully vaccinated means to complete the full brand vaccination protocol, and therefore one single shot of AstraZeneca, Pfizer-BioNTech, Moderna, Sinopharm or Sinovac after Covid-19 recovery is NOT considered being fully vaccinated.